Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8797 |
High Similarity |
NPD3027 |
Phase 3 |
0.8582 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD4625 |
Phase 3 |
0.8507 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8467 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8321 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8175 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8129 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8102 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8071 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8071 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD37 |
Approved |
0.7941 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7926 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7923 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7907 |
Intermediate Similarity |
NPD228 |
Approved |
0.7868 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.781 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7761 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7755 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7681 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7676 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7615 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7615 |
Intermediate Similarity |
NPD3022 |
Approved |
0.761 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7564 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7518 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7469 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7434 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7432 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7421 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.741 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7383 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7381 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7376 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7376 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7355 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7348 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7338 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7338 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7328 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7319 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7279 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7278 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7209 |
Intermediate Similarity |
NPD846 |
Approved |
0.7209 |
Intermediate Similarity |
NPD940 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7194 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7192 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7188 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7185 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7183 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7163 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7152 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7114 |
Intermediate Similarity |
NPD1607 |
Approved |
0.711 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7107 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7105 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7051 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD27 |
Approved |
0.7048 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7044 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7044 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7042 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7029 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7029 |
Intermediate Similarity |
NPD709 |
Approved |
0.7029 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7027 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7018 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7013 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3091 |
Approved |
0.6994 |
Remote Similarity |
NPD4663 |
Approved |
0.6988 |
Remote Similarity |
NPD2969 |
Approved |
0.6988 |
Remote Similarity |
NPD2970 |
Approved |
0.6987 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6981 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD943 |
Approved |
0.698 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.698 |
Remote Similarity |
NPD4140 |
Approved |
0.6978 |
Remote Similarity |
NPD7340 |
Approved |
0.6974 |
Remote Similarity |
NPD2438 |
Suspended |
0.6968 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6968 |
Remote Similarity |
NPD2677 |
Approved |
0.6968 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD8251 |
Approved |
0.6964 |
Remote Similarity |
NPD8099 |
Discontinued |
0.6964 |
Remote Similarity |
NPD8252 |
Approved |
0.6963 |
Remote Similarity |
NPD5451 |
Approved |
0.6959 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6959 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6957 |
Remote Similarity |
NPD6801 |
Discontinued |
0.695 |
Remote Similarity |
NPD1357 |
Approved |
0.6943 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD7843 |
Approved |
0.6933 |
Remote Similarity |
NPD6788 |
Approved |
0.6933
|
Remote Similarity |
NPD4581 |
Clinical (unspecified phase) |